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Abstract: Previous indirect 2D co-culture studies have demonstrated that mesenchymal stem cells
(MSCs) promote breast cancer (BC) progression through secretion of paracrine factors including growth
factors, cytokines and chemokines. In order to investigate this aspect of the tumour microenvironment
in a more relevant 3D co-culture model, spheroids incorporating breast cancer cells (BCCs), both cell
lines and primary BCCs expanded as patient-derived xenografts, and MSCs were established. MSCs in
co-cultures were shown to enhance proliferation of estrogen receptor (ER)/progesterone receptor
(PR)-positive BCCs. In addition, co-culture resulted in downregulation of E-cadherin in parallel with
upregulation of the epithelial-mesenchymal transition (EMT)-relation transcription factor, SNAIL.
Cytoplasmic relocalization of ski-related novel protein N (SnON), a negative regulator of transforming
growth factor-beta (TGF-β) signalling, and of β-catenin, involved in a number of pathways including
Wnt signalling, was also observed in BCCs in co-cultures in contrast to monocultures. In addition,
the β-catenin inhibitor, 3-[[(4-methylphenyl)sulfonyl]amino]-benzoic acid methyl ester (MSAB),
mediated reduced growth and invasion in the co-cultures. This study highlights the potential role for
SnON as a biomarker for BC invasiveness, and the importance of interactions between TGF-β and
Wnt signalling, involving SnON. Such pathways may contribute towards identifying possible targets
for therapeutic intervention in BC patients.
Keywords: spheroid co-culture model; tumour stroma; mesenchymal stem cells (MSCs); tumour
microenvironment (TME); epithelial-mesenchymal transition (EMT); ski-related novel protein N
(SnON); Wnt signalling; TGF-β signalling
1. Introduction
There is growing recognition of the importance of the tumour microenvironment (TME), especially
cells within the stroma, in determining biological characteristics of cancer cells such as proliferation,
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invasion and drug resistance [1–6]. Drugs specifically targeting the stroma are being investigated [7],
but appropriate models are required in order to identify relevant targets.
During cancer development, there is active recruitment of mesenchymal stem cells (MSCs) from
bone marrow to the TME where MSCs are educated by cancer cells to form cancer-associated fibroblast
(CAF)-like cells [8]. The presence of several growth factors and chemokines including hepatocyte
growth factor (HGF), monocyte chemotactic protein-1 (MCP-1), interleukin-6 (IL-6), transforming
growth factor-beta (TGF-β) and CCL-5 in MSC-conditioned medium in 2D suggests that, once within
the TME, MSCs secrete growth factors that promote tumour growth, epithelial-mesenchymal transition
(EMT) and invasion through direct paracrine actions and remodelling of extracellular matrix [8–11];
thus, activated signalling axes identified in this way may provide therapeutic targets.
However, studying the impact of MSC-driven paracrine signalling on BC progression in 2D may
not be an ideal approach. In 3D, extracellular matrix (ECM) supports cells through focal adhesion
and participates in cell signalling by promoting interaction between growth factors and cell surface
receptors [12,13]. In addition, in 2D cell culture systems, lower numbers of gap junctions prevent
exchange of ions and secondary metabolites and block removal of waste materials [14]. Alternatively,
in vivo xenograft models have been used [15] but cross-species interaction between human tumour and
murine stromal cells [16] may mask the real signalling axes activated in cancer cells by human MSCs.
In contrast, 3D spheroids potentially provide a useful system for modelling heterotypic interactions,
overcoming some of these problems, and are increasingly being used for drug screening and drug
penetration studies [17–20]. In spheroids, cells grow in aggregates that result in cell–cell interactions
and, under some conditions, the nutrition and oxygen gradients observed in real tissue [21]. In addition,
potential for incorporation of ECM facilitates cell–matrix interaction [22].
A high stroma–tumour ratio has been shown to be a poor prognostic indicator for breast cancer
patient overall survival and distant metastasis-free survival [23]. Uncontrolled cell proliferation is an
indication of the onset of neoplasia and a risk factor in patients [24,25], while epithelial-mesenchymal
transformation (EMT) facilitates invasion [26]. Therefore, understanding the molecular mechanisms
underlying breast cancer progression and the role of the stroma in driving it is important.
Hence, we chose to investigate the potential of using spheroid co-culture to determine the influence
of MSCs on breast cancer cell (BCC) proliferation and acquisition of an invasive phenotype. We have
studied paracrine signalling, which together with juxtracrine interactions plays an important role in
the tumour microenvironment and induction of EMT [27,28]. CAFs secrete various growth factors such
as TGF-β, HGF, FGF and chemokine CXCL12/SDF-1 (C-X-C motif chemokine ligand 12 or Stromal
cell-derived factor 1), which together promote tumour growth, EMT and invasion in cancer cells [4].
Here, we have focused on components of two pathways, known to be involved in crosstalk between
paracrine signalling axes in order to illustrate the potential applications of this model system and to
explore the contribution of these factors in BC.
β-catenin is a well-known component of the Wnt pathway [29] but also serves as a downstream
molecule for EGF/AKT and CCL5 signalling axes [30,31] and, in its non-phosphorylated form,
is transcriptionally active enhancing expression of Jun, c-Myc and Cyclin-D [32]. Increased cytoplasmic
and nuclear levels ofβ-catenin are found in the S and G2/M phases of proliferating cells [33], and nuclear
localisation of β-catenin leads to activation of cyclin-D1, important in regulation of the cell cycle in
colorectal cancer [34].
TGF-β plays an important role in EMT and metastasis in cancer cells [35]. It regulates several
signalling axes including Extracellular signal-regulated kinase (ERK), p38, mitogen-activated protein
kinase (MAPK), c-Jun N-terminal kinase (JNK), Phosphatidylinositol-3-kinase (PI3)-protein kinase B
(PKB, also known as AKT), acting primarily as a tumour suppressor in premalignant epithelial cells but
switching to an EMT promoter as cancer evolves [36]. Ski-related novel protein N (SnON) antagonises
the TGF-β signalling pathway via binding to the Smad protein and interrupts its interaction with
co-activators [37].
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Thus, given the known crosstalk between TGF-β signalling and other pathways including Wnt [11],
the association of β-catenin with increased proliferation and poor survival in BC patients [38] and the
observation that shRNA-mediated knockdown of SnON has been shown to increase migration and
invasion in breast and lung cancer cells [39]. The involvement of β-catenin and SnoN downstream of
MSC-mediated paracrine signalling was investigated in a spheroid co-culture model of breast cancer.
2. Results
2.1. MSCs Promote Proliferation in MCF-7 Breast Cancer Cells in Spheroid Co-Cultures
Initially, a number of alternative approaches were taken in order to assess co-culture models and
to identify models suitable for further use. The growth of spheroid co-cultures of luminal (MCF-7)
and triple negative (MDA-MB-231) cells with MSCs as well as monoculture controls (MCF-7 or
MDA-MB-231 only) was investigated using spheroid projected area measurements (Figure 1A) or
Alamar Blue assays (Figure 1B). Given the higher numbers of cells in the co-cultures, there were higher
signals in in the co-culture models compared with monocultures at all timepoints assessed (d3, d5 and
d7). Additionally, although not apparent from the area measurements, there was a small reduction
in viability observed in some of the models at d7 compared to d5. Live/dead staining using Calcein
acetoxymethyl (AM) and propidium iodide (PI) confirmed the slight reduction in cell viability at later
timepoints, particularly in the core of the spheroids (Figure 1C). To determine the location of MSCs
in the co-cultures and their retention over time, enhanced green fluorescent protein (eGFP)-labelled
MSCs were used to establish spheroids (Figure 1D). The eGFP signal was strongest in the core of the
spheroids, suggesting that the small population of dying cells in the core of the spheroids based on
Calcein AM/PI staining consisted of MSCs.
Since the area measurements, AlamarBlue and live-dead staining approaches do not distinguish
between signals derived from cancer cells and MSCs, a more direct approach to measure proliferation
in the cancer cells was taken. CellTrace Violet diffuses into cells, where it is cleaved by intracellular
esterases to yield a highly fluorescent compound shared between daughter cells on cell division,
resulting in a distinct peak separate from that in the parental cells that can be detected by flow cytometry
analysis [40]. Details of the analysis are shown in Figure S1, and the results are summarised in Figure 1E.
Co-culture of MDA-MB-231 with MSCs had little effect on their rate of division (73% vs. 85% at d3
and 79% vs. 86% at d5). However, for the MCF7 cells, there was a notable increase in the number of
dividing cells in the co-culture compared with the monoculture, especially at d3 (73% vs. 15%).
To confirm and localise the proliferating BCCs in the MCF-7 co-cultures, paraffin-embedded
sections of microarrayed MCF-7 mono and co-culture spheroids were probed for Ki-67. In the
monoculture spheroids, a few Ki67-positive cells were seen and, in general, the Ki67-positive nuclei
were only weakly stained; interestingly, low levels of Ki67 have previously been observed in breast
cells at the G1/S transition in slowly cycling cells, suggesting that low intensity as well as low Ki67
counts are associated with cells which are not proliferating [41]. In the MCF-7 co-cultures, a large
number of brightly stained, Ki67-positve nuclei were observed (Figure 1F). Many of these were in
the zone outside the core where a low eGFP signal was observed in the BCC:MSC-eGFP co-culture
spheroids. Within and particularly at the edges of the core, mesenchymal-like cells, likely to be
MSCs, were observed which were rarely Ki67-positive; however, some epithelial cancer cells were
also observed within the core, many of which were Ki67-positive. Thus, this confirmed the CellTrace
Violet data, which suggests that it is mainly the BCCs within the MCF-7 co-culture spheroids which
are proliferating.
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number (B) was assessed at each time point using the AlamarBlue assay; live/dead cell staining (C) 
was carried out using Calcein acetoxymethyl (AM) and Propidium iodide (PI) respectively, together 
with Hoechst staining to localise individual cells. Images shown represent a single z-slice captured 
using 10× magnification. (D) Spheroids were additionally formed using enhanced green fluorescent 
protein (eGFP)-labelled MSCs in order to investigate MSC localisation and retention in the co-
cultures. Fluorescent images shown represent a single z-slice captured using fluorescent microscopy. 
(E) To investigate proliferation in the cancer cells directly, spheroids were established using BCCs 
Figure 1. Mesenchymal stem cells (MSCs) promote proliferation of breast cancer cells (BCCs) in spheroid
co-culture. BCC cancer cells (MCF-7 or MDA-MB-231) were cultured as spheroids alone (monoculture)
or MSCs at a 1:2 (cancer cells: MSCs) ratio (co-culture). (A–C) The spheroids were analysed at d3,
d5 and d7 after initiation to determine projected area (A) based on image analysis of bright field
micrographs captured at each time point from three independent replicates; relative cell number (B) was
assessed at each time point using th Ala arB ue ass y; live/dead cell staining (C) was carried out using
Calcein acetoxyme hyl (AM) and Propidium iodide (PI) respectively, toge her with Hoechst staining to
localise individual cells. Images shown represent a single z-slice captured usin 10×magnification.
(D) Spheroids were additionally formed using enhanced green fluorescent protein (eGFP)-labelled
MSCs in order to investigate MSC localisation and retention in the co-cultures. Fluorescent images
shown represent a single z-slice captured using fluorescent microscopy. (E) To investigate proliferation
in the cancer cells directly, spheroids were established using BCCs that had been labelled with Cell-trace
violet, then disaggregated and analysed by flow cytometry. The proportion of cancer cells which had
divided between initiation of spheroids and d3 or d5 of culture was calculated (see Supplementary
Figure S1 for details) using Weasel flow cytometry-analysis software. (F) Following fixation and
paraffin-embedding, MCF-7 spheroids harvested at d5 were immuno-stained using anti-Ki-67 antibody.
Brown colour indicates the presence of the Ki-67-positive nuclei. Images were captured at 20× and 60×
magnifications using a Leica DFC480 digital microscope. Statistical significance between consecutive
time points is shown for each condition, based on two-way repeated measures ANOVA: *, **, *** and
**** represent p-values of <0.05, <0.01, <0.001 and <0.0001 respectively. Scale bars represent 100 µm
(C,D,F) or 50 µm (F inset).
2.2. MSCs Promote Invasion in Noninvasive BC Cell Line MCF-7
Using a concentration of basement membrane extract (BME, 3 mg/mL) that supports the invasion of
triple negative breast cancer (TNBC) MDA-MB-231 monoculture spheroids, the impact of mesenchymal
cells on the invasive phenotype of MCF-7tdTomato in the presence or absence of MSCs was assessed.
In the case of spheroid co-cultures, mobility of the cancer cells beyond the original boundaries of the
spheroid was observed (Figure 2Ai) and was significantly higher (p < 0.05) in the co-cultures compared
with monocultures (Figure 2Aii). In contrast, no such migrated MCF-7tdTomato cells were observed
either in embedded monoculture spheroids or in non-embedded spheroid co-cultures (Figure 2Ai).
Some invasion of eGFP-labelled MSCs into the surrounding matrix was also observed (Figure 2Ai,
lower panel).
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Figure 2. Mesenchymal stem cell (MSC)-induced invasion, cytoskeletal organisation and
epithelial-mesenchymal transition (E T) in MCF-7 spheroid co-cultures. MCF-7s spheroid monocultures,
or co-cultures with MSCs w re emb ded in high-gelling base ent membrane extract (BME, 3 mg/mL)
to investigate invasi ciated phenotypic markers. Non-emb ded spheroids were examined
as contr ls. (A) Spheroids formed usi t ato and eGFP-labelled MCF-7s and MSCs respectively
were imaged at 24, 48 and 72 h. (i) Cancer cells (red) within co-cultures embedded in BME or controls at
72 h are shown in the upper panel. Images in the lower panel indicate that some MSCs are also invading.
Regions of localised spheroid invasion are shown as insets in the lower panel. Scale bar 100 µm.
(ii) Based on red fluorescence measurements, invasion of MCF-7 cells was quantified at 72 h as invasion
index (perimeter/circumference). Statistical significance was assessed using a Student’s t-test, * indicates
p < 0.05. (B) Staining with Phalloidin to investigate the impact of MSCs on F-actin reorganisation (green)
in MCF-7 at the outer edges of the spheroids. Maximum intensity projections of 5 z-slices obtained from
confocal imaging using a L ica TCS SPE system are sho n. Scale bar 50 µm. (C) immunohistochemistry
(IHC) for E-cadherin was erf rmed on 5 µm se tions of paraffin-embedded, arrays of spheroid mono
and co-cultures. (D) Relative expressio (2-∆∆Ct) of EMT markers (mean±SEM in two independent
replicates) was assessed by qRT-PCR in FACS-sorted MCF-7 tdTomato cells from spheroid co-culture.
Significant changes in expression relative to the control monoculture are indicated (* p < 0.05 and
** p < 0.01).
In the MCF-7 spheroid co-cultures, cytoskeletal reorganisation was also observed. Phalloidin staining
of spheroid monoculture showed a honeycomb structure associated with well-differentiated epithelial
cells with F-actin at the plasma membrane surrounding the cells (Figure 2B). In contrast, rearrangement
of F-actin occurred in MCF-7 with loss of the honeycomb pattern in spheroid co-cultures as previously
observed in mammary epithelial cells treated with TGF-β [42]. Since such F-actin reorganisation
was also asso i ted with EMT [42], expression of E-cadherin was ass ssed by immunohistochemical
staining of par ffin-embedded spheroids and further co firmed the loss of epithelial characteristics in
MCF-7 cells in co-culture (Figure 2C). Furthermore, the gene expressions of EMT markers vimentin,
SNAIL, TWIST, E-cadherin and Zeb1 were investigated in MCF-7-tdTomato cells FACS-sorted from
co-culture spheroids and compared with that in monoculture spheroids (Figure 2D). Surprisingly,
the expressions of vimentin and Zeb1 were unchanged and there was a significant reduction in
TWIST expression. However, consistent with the protein expression, E-cadherin gene expression was
significantly downregulated in the co-culture (p < 0.05, paired t-test). This was paralleled by significant
upregulation of SNAIL expression (p < 0.01, paired t-test).
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2.3. MSCs Induce Proliferation and Promote Invasion in Estrogen Receptor (ER)/Progesterone Receptor
(PR)-Negative PDXs in Spheroid Co-Culture
To further assess the effects of MSCs on BCC proliferation and invasion in 3D models using
patient-relevant cells, BCC cells derived from breast cancer patient-derived xenograft (PDX) samples
were used in the spheroid co-culture models. BR15 derived from an ER/PR-positive patient tumour
sample and BR8 derived from an ER/PR-negative patient tumour sample associated with lymph node
and brain metastasis were used.
As observed in the cell-line spheroid models, there was growth over time but a slight reduction in
overall cell viability by day 7 (Figure 3A) and a stronger effect in the ER positive BR15 model compared
to triple negative BR8. In addition, MSCs tended to cluster in the centre of the spheroids (Figure 3B)
and there was good retention of the MSCs over time (Figure 3C). We next investigated the effect of
co-culture with MSCs on invasion of non-invasive BR15 spheroids, following embedding in BME.
Although the edges of the BR15 spheroid monocultures remained regular, finger-like projections were
observed in the spheroid co-culture starting from 48 hours (Figure 3D), which is consistent with the
results observed in the MCF-7 in the spheroid co-culture (Figure 2A) with statistically significantly
higher invasion in the co-cultures compared with the monocultures (Figure 3E).
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Figure 3. Mesenchymal stem cells (MSCs) promote proliferation in breast cancer cells isolated
from patient-derived xenografts (PDXs) and induce invasion in a non-invasive estrogen receptor
(ER)/progesterone ceptor (PR)-negative PDX in spheroid co-culture. Sph roid monocultures and
co-cultures of PDXs BR8 (ER/PR-negative) and BR15 (ER/PR-positive) were established. (A) AlamarBlue
was used to assess viability on days 3, 5 and 7. Statistical significance was determined using two-way
repeated measures ANOVA with Sidak pos -hoc test, shown relativ to day 3. (B) Fluorescence
imaging was used to assess location and survival of MSC-eGFP, scale bar 100 µm. (C) Total spheroid
projected area for the co-cultures was measured from bright-field images at each time point. Statistical
significance was determined using one-way ANOVA with Tukey post-hoc test, shown relative to day 3.
(D) For BR15, the effect of co-culture with MSCs on invasion into BME was assessed using Brightfield
and Fluorescent microscopy at 10x magnification. Scale bar 100 µm, 50 µm inset. (E) Quantification of
invasion index (perimeter/circumference) for BR15 invasion at 72 h for monoculture and co-culture.
Statistical significance was determined using the Student’s t-test. *, ** and **** indicate p-values of
<0.05, <0.01 and <0.001 respectively.
2.4. MSCs Promote Nuclear Clearance of SnON and Promote β-Catenin Activation in MCF-7 in
Spheroid Co-Culture
To study the mechanism of induced proliferation and invasion by MSCs in BCCs, we focus
our attention on the crosstalk between TGFβ and Wnt signalling as known effectors of the tumour
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microenvironment on BCC behaviour and inducers of EMT [43]. We first studied the expression of
SnON, a known negative regulator of TGFβ signalling [44]. SnON is mainly a nuclear protein but
becomes more cytoplasmic in ER/PR-negative grade III ductal breast tumours with high expression
of Ki67 and HER2 amplification [45], representing a more aggressive subtype of BC. Similarly, it has
been reported that cytoplasmic and nuclear levels of β-catenin increase in the S and G2/M phases of
proliferating cells [33]. Since co-culture with MSCs increased the expression of Ki-67 and invasion
in MCF-7 cells, immunohistochemistry (IHC) for SnON and β-catenin expression was performed
and revealed nuclear localisation of SnON in MCF-7 in the spheroid monoculture, while cytoplasmic
expression of SnON in MCF-7 in co-culture spheroids imitates the SnON localisation in the cytoplasm
of MDA-MB-231 (Figure 4Ai). On the other hand, cytoplasmic localisation of β-catenin in MCF-7 in
spheroid co-culture contrasted with its presence at the plasma membrane of cells demonstrated in
monocultures (Figure 4Aii). Controls for the SnON and β-catenin staining are shown in Figure S2.
Moreover, from visual comparison of fluorescence staining intensity for β-catenin in spheroid mono-
and co-culture of MCF-7, it appears that the presence of MSCs stabilizes β-catenin in co-culture
(Figure 4B).
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Figure 4. Mesenchymal stem cells ( s) induce a cytoplasmic shift of ski-related novel protein
N (SnON) and pro ote BCC progression through β-catenin activation. MCF-7 monoculture
and co-culture spheroids were established and examined for expression of SnON and β-catenin,
and the effect of β-catenin inhibition on spheroid growth and invasion was assessed. MDA-MB-231
monoculture spheroids were used as controls. (A) IHC staining for SnON (i) and β-catenin (ii).
Brown 3,3′-Diaminobenzidine (DAB) indicates the locati f the target proteins; images were captured
at 60× objective using a slide scanner, Ventana 2000. (B) Confocal images of fluorescent staining of
β-catenin captured using a 20× objective. β-catenin appears green while 4′,6-diamidino-2-phenylindole
(DAPI stained cell nuclei blue. Colon tissue was used as a positive control. (C) AlamarBlue assay
was used to assess the effect of β-catenin inhibitor on MCF-7 spheroids (i) and the mean ±SEM IC50
values calculated (ii). Statistical significance between effects on monoculture and co-culture is indicated
(** p < 0.01; t-test, n = 2). (D) Invasion of spheroid co-cultures embedded into 3 mg/mL BME was imaged
at 72 h at 10×magnification. Spheroids treated with 6 µM 3-[[(4-methylphenyl)sulfonyl]amino]-benzoic
acid methyl ester (MSAB) were compared with non-embedded, untreated or control-treated spheroids.
The invasive front in each condition is highlighted using a yellow border drawn in ImageJ.
(E) The invasion index (perimeter/circumference) under each condition was quantified. Significant
differences were calculated using one-way ANOVA with the Tukey post-hoc test (* indicates p < 0.05).
Cancers 2020, 12, 2290 8 of 16
Since changes in the distribution of β-catenin observed by IHC and fluorescent staining suggested
a possible role for β-catenin in BC progression, the effect of β-catenin inhibition on MCF-7 cells in
spheroid co-culture was investigated using MSAB [46]. Spheroid mono and co-culture were treated
with a range of concentrations of MSAB (1 µM to 40 µM) for 48 h and viability assessed by Alamar
blue assay, ensuring that the concentration of dimethyl sulphoxide (DMSO) vehicle was at least 10%
lower than the cytotoxic concentration (Figure S3). A dose-dependent decrease in cell proliferation was
observed (Figure 4Ci) and inhibition of proliferation of the co-culture spheroids required a significantly
higher MSAB concentration (p < 0.01) compared to the monoculture (Figure 4Cii). Application of MSAB
at 6 µM (approx. IC50 based on viability assay) suppressed invasion of MCF-7 spheroid co-cultures
embedded in matrix resulting in a rounded morphology similar to that of non-embedded co-cultures
and controls (Figure 4D) and a significant reduction in invasion compared with the DMSO control
(Figure 4E).
3. Discussion
Using a spheroid model, we demonstrate the influence of bone-marrow-derived MSCs on BCC
proliferation, EMT and invasion in direct co-culture. Importantly, these effects were observed in models
established using primary BCCs expanded as PDXs as well as those using standard cell lines. We also
highlight a potential mechanism underlying these observations involving SnON and β-catenin.
Although spheroid area, metabolic assays such as AlamarBlue, and live-dead staining can provide
some indication of cell survival and proliferation within spheroids [47], interpretation of such data
in direct co-culture models is more difficult. Instead, we used the CellTrace Violet assay, which
enables labelling and tracking of the individual population of cells under investigation. This enabled
demonstration of a specific effect of the MSCs on breast cancer cell proliferation, which was confirmed
by immunohistochemistry staining of paraffin-embedded spheroids for Ki67.
Additionally, we demonstrated enhanced invasive capacity in breast cancer cells directly
co-cultured with MSCs in 3D. Again, analysis of the BCCs isolated by FACS from these direct
co-cultures, together with immunohistochemistry staining, suggest that the normally noninvasive
ER/PR-negative BCCs have reduced E-cadherin expression when co-cultured with MSCs. This is
consistent with data from co-culture studies in which enhanced proliferation and induction of EMT was
observed when colorectal cancer spheroids were subjected to indirect co-culture with fibroblasts [48]
and with observations of crosstalk between multiple pathways capable of driving EMT [49].
In the current study, downregulation of E-cadherin was paralleled by upregulation of SNAIL
expression. SNAIL is known to be a repressor of E-cadherin expression [49]. In liver fibrosis, EMT is
induced via upregulation of SNAIL and is dependent on TGF-beta signalling from stromal cells [50].
In breast cancer, upregulation of SNAIL is associated with poor prognosis and tumour recurrence,
and overexpression of SNAIL is sufficient to induce EMT in primary tumour cells in vitro and to
increase recurrence in vivo [51]. Although TWIST and Zeb1 are also considered to be master regulators
of EMT [52], we did not observe upregulated expression of these genes in our model. In some studies
TWIST is described as being a regulator of SNAIL expression [49]; however, in other studies, no effect
of TWIST overexpression in primary mammary epithelial cells on SNAIL was observed, suggesting
that, at least in some contexts, these transcriptional regulators of EMT can function independently [53].
Additionally, as we did not observe marked changes in vimentin expression, the BCCs may be
undergoing partial EMT in which epithelial and mesenchymal markers are expressed concurrently [54].
Interestingly, consistent with our observations of both cancer and mesenchymal cells at the invading
front, partial EMT can support collective migration of cells including those with epithelial and
mesenchymal phenotypes [55].
Given the role of TGF-β in cancer cell proliferation and EMT induction and the role of SnON
as a negative regulator of TGF-β signalling [45], we hypothesised that it may be involved in the
MSC-driven effects on proliferation and EMT that we had observed. Our observation of an association
between a more invasive phenotype and the shift to cytoplasmic expression of SnON in MCF-7 when
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co-cultured with MSCs is interesting in light of increased cytoplasmic SnON associated with poor
prognostic features in ductal breast cancer including higher Ki67 expression and loss of ER/PR [45],
the latter usually associated with an invasive phenotype. Although the precise mechanism linking
SnON with all of these features is not clear, it is known to interact with SMADs to prevent TGF-β
signalling [44], and previous studies demonstrated TGF-β-driven downregulation of E-cadherin and
F-actin reorganisation in a SnON-knockdown lung cancer cell line [39]. Thus, SnON may normally
repress TGF-β signalling but relocalises to the cytoplasm in more invasive breast cancer, and our
data suggest that this may be driven by other paracrine signals, including crosstalk between TGF-β
signalling and other pathways.
Our data showing cytoplasmic localisation of β-catenin and MSAB inhibition of growth in
spheroid co-cultures suggest the presence of active β-catenin in MCF-7s in the presence of MSCs.
This may occur through β-catenin’s known effect on cell proliferation regulatory genes including
C-MYC, Cyclin D and ID2 (inhibitor of DNA binding 2) [56]. Interestingly, β-catenin also interacts with
SNAIL and drives EMT, characterized by F-actin polarization and activated by the ERK pathway [57].
Further, it has been shown to be directly involved in TGF-β-induced EMT via interaction between
phosphorylated β-catenin and SMADs [58], again emphasizing the complex interplay between the
paracrine signalling pathways driving stromal influences in cancer. In the future, this direct co-culture
system will allow further investigation of the role of the tumour microenvironment driven by paracrine
or juxtracrine signalling.
4. Materials and Methods
4.1. Cell Culture Conditions
Wildtype BCCs, MCF-7 and MDA-MB-231 (obtained from the National Cancer Institute, USA,
as part of the NCI-60 panel) or tdTomato-transduced MCF-7 (MCF-7tdTomato) were maintained in
phenol red-free Roswell Park Memorial Institute( RPMI)-1640 medium supplemented with 10% foetal
bovine serum (FBS) and 2 mM L-Glutamine (Sigma Aldrich, St. Louis, MO, USA) Wildtype or green
fluorescent protein (GFP) gene-transduced bone marrow-derived mesenchymal stem cells (MSC or
MSC-eGFP respectively) were maintained in mesenchymal stem cell medium (MSCM) supplemented
with FBS and mesenchymal stem cell growth supplement (MSCGS) (ScienCell, Carlsbad, CA, USA).
For both BCC lines, passages below 40 were used, while for MSCs, passage numbers 8 to 10 were used.
Mycoplasma tests were performed regularly throughout the study to avoid using infected cells.
4.2. Patient-Derived Xenografts
Cells were isolated from breast cancer PDXs for use in spheroid models, using protocols previously
established in our laboratory [59]. BR15 had been expanded from an ER/PR-positive breast tumour
and no tumour was associated with the lymph nodes resected in parallel. BR8 was expanded from
an ER/PR-negative tumour; a number of associated lymph nodes contained tumours, and a brain
metastasis was present. Both were obtained as fresh surgical material from tumour resections at
Nottingham University Hospitals NHS Trust, collected with informed patient consent and National
Research Ethics Service (NRES) approval (NRES REC 10/H0405/6). Samples were used in accordance
with NRES approval (NRES REC 08/H0403/37). Female CD-1 NuNu mice (8–10 weeks), purchased
from Charles River UK and allowed to acclimatise for a week prior to use, and female Rag2−/− γc−/−
(RAG2G, 8–10 weeks) bred in-house under PPL P375A76F, both immunodeficient strains, were used in
this project. Mice were maintained in Individually Ventilated Cages (IVCs) (Tecniplast UK) within
a barriered unit illuminated by fluorescent lights set to give a 12 hour light-dark cycle (on 07.00,
off 19.00), as recommended in the United Kingdom Home Office Animals (Scientific Procedures) Act
1986. The room was air-conditioned by a system designed to maintain an air temperature range of
21 ± 2 ◦C and a humidity of 55% + 10%. Mice were housed in social groups during the procedure and
provided with irradiated bedding and autoclaved nesting materials and environmental enrichment
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(Datesand, Bredbury, UK). Sterile irradiated 5V5R rodent diet (IPS Ltd, UK) and irradiated water
(SLS, UK) was offered ad libitum. Tissue was generated by implantation of tumour fragments using
an implant trochar (VetTech, Congleton, UK) into the mammary fat pad of the mice (RAG2G or
CD1 nude mice-strain used in each case was determined by suitability and availability) with MSCs
and MatrigelTM, followed by serial passage when needed, by experienced in vivo technicians under
project license PPL 3003444. Tumours were measured weekly using Vernier calipers, and the volumes
were calculated using the formula V = ab2/6, where a is the length and b is the width. Mice were
also weighed weekly and checked daily by an experienced technician. National Cancer Research
Institute (NCRI) guidelines for the welfare and use of animals in cancer research, Laboratory Animal
Science Association (LASA) good practice guidelines, and Federation for Laboratory Animal Science
Associations (FELASA) working group on pain and distress guidelines were also followed, as were
the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines on the reporting of
in vivo experiments.
4.3. Establishing Spheroid Mono and Co-Culture
Spheroids were established using either cell lines or cells isolated from PDXs; 2K BCCs were
seeded alone for the spheroid monoculture, while for spheroid co-culture, 2K BCCs were mixed
with 4K MSC (wild-type or eGFP) and seeded in a 96-well Ultra-Low Attachment plate (Corning,
Corning, NY, USA) in a 200 µL volume per well. Extracellular matrix (ECM)-rich Cultrex (Trevigen
Inc., Gaithersburg, MD, USA) was included at a final concentration of 100 µg/mL for all models as it
was required to aid formation of tight round MDA-MB-231 spheroids. After centrifugation for at least
5 min at 300 Relative Centrifugal Field (RCF), the cultures were maintained in a cell culture incubator
at 37 ◦C with 5% CO2 in a humidified atmosphere.
The cell culture medium used for PDX spheroids was high glucose DMEM media supplemented
with 20% FBS, 2 mM L-glutamine, 1× antibiotic/antimycotic, 0.12% hydrocortisone and 0.09% insulin.
In some experiments, spheroids were treated with 3-[[(4-methylphenyl)sulfonyl]amino]-benzoic
acid methyl ester (MSAB, Sigma). Since DMSO is the solvent for MSAB and is toxic to cells,
cytotoxic concentration of MSAB was determined by the Alamar blue assay while incubating MCF-7
spheroid monoculture with DMSO at the concentration gradient range from 0–5% (Figure S3).
4.4. Live/Dead Cell Staining in Spheroid Culture
Spheroids were incubated with 2 µM Calcein AM (eBioscienc, San Diego, CA, USA) and 5%
(v/v) Propidium iodide (PI) (eBioscience, San Diego, CA, USA) [47] for 3 hours in the incubator in the
presence of 5% CO2 at 37 ◦C and were washed twice with 300 µl PBS by carefully removing 100 µL of
the media each time. Finally, fluorescent images of spheroids were captured using Nikon Eclipse TiE
or Okolab fluorescence microscopes.
4.5. AlamarBlue Assay
Spheroids were incubated with 10% (v/v) AlamarBlue (Thermo Fisher Scientific, Waltham, MA,
USA) for 90 min in the cell culture incubator, and the relative fluorescence (RFU) at different time
points was measured with the assistance of a plate reader (Fluostar Omega, BMG Labtech, Ortenberg,
Germany; FlexStation II, Molecular Devices, San Jose, CA, USA) at excitation and emission wavelengths
of 544 nm and 590 nm, respectively. Data shown has been normalized to the values for monoculture
day 3. For drug inhibition studies, the IC50 was calculated from the nonlinear drug response curve
using GraphPad Prism.
4.6. CellTrace Violet Assay
CellTrace Violet assay was performed according to the manufacturer protocol (ThermoFisher
Scientific, Waltham, MA, USA). Stained BCCs were seeded as above for spheroid mono and co-culture
with MSCs. In order to demonstrate the BCC proliferation in different conditions, the spheroid
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mono and co-cultures from day 3 and day 5, respectively, were dissociated using Accumax (Sigma,
St. Louis, MO, USA) (Figure S4) and the progressive decrease in signal intensity assessed by flow
cytometry at excitation and emission wavelengths of 405 nm and 450 nm, respectively, and then by
using Weasel software.
4.7. Spheroid Invasion Assay
Following formation of spheroids, the surrounding media was carefully removed from each well
and replaced with 100 µL of 3 mg/mL Cultrex in complete medium per well. After incubating for 1 h at
37 ◦C when the gel had set, complete medium was overlaid on top and images captured as required at
different time points.
4.8. Phalloidin Staining in Spheroid Mono and Co-Culture
Phalloidin staining was based on a previous study [60] but with minor modifications. Individual
spheroids were stained with 1× phalloidin (Phalloidin-iFluor 488 Reagent-Cytopainter; Abcam,
Cambridge) in an Eppendorf tube and embedded in polymerised high-gelling Cultrex (6 mg/mL)
within a hydrophobic barrier on a glass slide for imaging. Stained spheroids were imaged using a
Leica DMI4000B inverted microscope with a Leica TCS SPE laser scanning confocal setup.
4.9. RNA Extraction from FACS-Sorted MCF-7td Tomato in Spheroid Co-Culture and qRT-PCR
Following digestion of eighty spheroids, cells were FACS sorted and total RNA from eighty
spheroids from each condition was extracted using Trizol/chloroform procedure. Briefly, cell pellets of
MCF-7tdTomato from each condition were treated with 300 µl Trizol; 250 µl chloroform was added
with shaking for 5 min; and then, after a 10 min incubation at room temperature (RT), it centrifuged
at 12,000× g for 15 min at 4 ◦C. The aqueous phase was mixed with an equal volume of ice-cold
isopropanol in fresh centrifuge tubes and, then after 15 s of vigorous shaking, incubated for overnight at
−20 ◦C. Samples were centrifuged at 12,000 × g for 20 min at 4 ◦C to pellet the RNA, which was washed
twice in 75% ethanol and then resuspended in 8 µl Nuclease free water (NFW). The concentration
of RNA in each sample was determined using Nanodrop (NanoDrop 2000, Thermo Fisher Scientific,
Waltham, MA, USA).
cDNA prepared following the manufacturer’s protocol (GoSript™ Reverse Transcriptase) was
analysed by real-time PCR using the Power SYBR Green PCR master mix (Applied Biosystems) using
Hypoxanthine Phosphoribosyltransferase (HPRT) as an internal control in a StepOne PCR machine
using the following cycles: 95 ◦C for 10 min, hot start for enzyme activation followed by 40 cycles at
95 ◦C for 15 s (denaturation) and 60 ◦C for 60 s (annealing/extending). Primer sequences (purchased
from Eurofins, Luxembourg) used at a final concentration of 500 nM are shown in Table 1.
Table 1. Quantitative Real-time PCR primers for epithelial-mesenchymal transition (EMT) markers.







4.10. Preparation and Immunostaining (IHC and IF) Analysis of Spheroid Microarray
Spheroids were washed three times with PBS and then fixed overnight at 4 ◦C in 4% paraformaldehyde
(PFA). After two further PBS washes, they were embedded in 2% agarose, fixed in 1×Neutral buffer
formalin (NBF) and paraffin embedded to prepare spheroid microarrays according to the published
protocol [61].
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Sections were cut, dewaxed and stained as before [61] except the primary antibody incubation was
performed overnight at 4 ◦C. IHC and Immunofluorescence (IF) staining for β-catenin was performed
following the protocol (Protocol ID: 283) provided by Cell Signalling Technology (CST). Details of
antibodies and the secondary detection reagents used with each are given in Table 2.
Table 2. Antibodies used for IHC.
Antibodies Dilution Source
Monoclonal mouse (Mse) anti-Ki67 Ab (MIB-1) 1:40 DAKO
Monoclonal Mse anti-E-cadherin Ab (Clone NCH-38) 1:50 DAKO
Monoclonal mse anti-SnON (Clone OTI1A6) 1:150 LS Biosciences
β-catenin (D10A8) XP®rabbit monoclonal Ab 1:100 Cell Signalling Technology
Mse IgG1, Negative control 1:50 DAKO
Rabbit IgG1, Negative control 1:100 DAKO
Polyclonal rabbit anti-mouse IgG-Biotinylated 1:300 DAKO
SignalStain®Boost Detection Reagent (HRP, Rabbit) neat Cell Signalling Technology
Chicken anti-Rabbit IgG, Alexa Fluor 488 1:300 Thermo Fisher Scientific
4.11. Image Analysis
All image analysis was carried out using the ImageJ software distribution Fiji [62]. Raw data files
were used for all quantitative analysis. The wand tool in Fiji was used to trace the spheroid perimeter
and to determine the projected area. Imaging artefacts were removed manually where these were
found to prevent accurate spheroid tracing. The measured area enclosed by the spheroid perimeter
was used to calculate the spheroid radius, r, assuming a perfect circular cross-section, and area was
calculated using the formula 2pir2. The same method was used for calculation of invasion index,
defined as (spheroid perimeter)/2pir, which measures the departure of the shape from a perfect circle.
Prior to tracing the spheroid perimeter for invasion analysis on bright field images, a “find edges”
operation was carried out using the Fiji software.
4.12. Statistical Analysis
Prism v.7.0d (GraphPad) and SPSS v.26 (IBM) were used for statistical analysis. All error bars
shown represent mean and standard deviation unless otherwise indicated. To determine statistical
significance, the Student’s t-test and one-way or two-way repeated measures ANOVA were used as
appropriate. For multiple comparisons, the Tukey HSD and Sidak post hoc tests were used for one-way
and two-way ANOVA, respectively. Statistical significance for all tests was declared at p < 0.05.
5. Conclusions
To restore mesenchymal cell-driven signalling, we have established a co-culture model
incorporating BCCs together with MSCs, using either BC cell lines or BCCs isolated from patient-derived
xenografts. Using these models, we have shown that there is enhanced proliferation and invasion of
ER/PR-positive BCCs in the co-culture models compared with the monocultures. Care must be taken
in interpreting effects on spheroid size, metabolic assays and even live/dead staining in co-culture
models where the readouts are more complex due to the presence of multiple cell populations. Thus,
we confirmed effects on proliferation using CellTrace Violet, which allows labelling and tracking
of individual populations of cells, as well as through immunohistochemistry, which allows in situ
localization of relevant markers.
The enhanced invasion observed when the co-culture spheroids were transferred into BME involves
partial EMT, potentially mediated by upregulation of SNAIL and involving collective migration. As well
as changes in EMT marker expression in the co-culture models, we observed relocalisation of TGF-β
signalling repressor, SnON and β-catenin, suggesting that the phenotypic changes may occur via
activation of TGF-β and Wnt signalling, a concept supported by inhibition of proliferation and invasion
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by a β-catenin inhibitor. Future studies may further elucidate the complex interactions between the
multiple paracrine signalling pathways involved in mesenchymal cell-driven phenotypic changes in
BCCs that result in disease progression. Direct co-culture models such as the one we have described
here are important in allowing such studies to be carried out, reducing the use of animals to investigate
such complex interactions. They also allow in vitro investigation using “close-to-patient” models such
as the PDX cells utilized here, which will allow more robust and clinically relevant identification of
novel drug targets and drug screening.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6694/12/8/2290/s1,
Figure S1: CellTrace Violet assay; Figure S2: Controls for SnON and β-catenin IHC staining; Figure S3: DMSO
tolerance test, Figure S4: Accumax-mediated dissociation of spheroid.
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